Point State Capital LP Eli Lilly & CO Transaction History

Point State Capital LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $5.83 Million - $6.85 Million	20,932 Added 100.0%	41,864 $13.6 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $5.83 Million - $6.85 Million	20,932 New	20,932 $6.79 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $4.69 Million - $5.83 Million	-20,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $4.5 Million - $5.58 Million	-20,000 Reduced 50.0%	20,000 $5.52 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $4.65 Million - $5.73 Million	-21,000 Reduced 34.43%	40,000 $9.24 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $511,137 - $661,151	2,831 Added 4.87%	61,000 $14 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $9 Million - $11.6 Million	-54,744 Reduced 48.48%	58,169 $10.9 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $2.76 Million - $3.66 Million	21,187 Added 23.1%	112,913 $19.1 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $12.2 Million - $14.1 Million	-83,230 Reduced 47.57%	91,726 $13.6 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $21.9 Million - $26.3 Million	160,485 Added 1109.01%	174,956 $28.7 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $1.72 Million - $2.13 Million	14,471 New	14,471 $2.01 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $3.5 Million - $4.09 Million	-31,600 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $3.52 Million - $4.14 Million	31,600 New	31,600 $4.1 Million

4,033

737M

8.26M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $746B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.